Prions and Oral Cavity: The Oblivious Single Handed Protein Machinery
Abstract
BACKGROUND: The world today is facing an unprecedented situation with the spread of novel COVID-19. Covid era has brought the whole world to its knees. Oral health care professionals are at the risk of acquiring numerous diseases which amounts to occupational hazards. Now is the time to widen our horizons and look at different spectrum of diseases, prions being one of them. The short clinician course and long incubation period poses many challenges to this group of neurodegenerative diseases. AIM: The aim of this review is to highlight uncharted aspects of prions and oral health. REVIEW DETAILS: It sheds light on the spectrum of prion diseases. Since there is no known cure of this dreaded disease and it is ineffective with normal sterilization and disinfection procedures, prevention is the only way ahead. This review highlights the colliding world of prions and human body. This also keeps in mind the precautions and guidelines which will help health care professionals in combating this non curable fatal disease. CONCLUSION: Ensuing endeavors should be undertaken to help find plausible detection techniques, treatment options (if any), precaution and guidelines to be kept in mind to fight off this protein entity.
References
1. Cuille, J. & Chelle, P. L. (1939) C. R. Seances Acad. Sci. 208, 1058–1160.
2. Gordon, W. S. (1946) Vet. Rec. 58, 516–520.
3. Alpers, M. (1979) in Slow Transmissible Diseases of the Nervous System, eds.Prusiner, S. B. & Hadlow, W. J. (Academic, New York), Vol. 1, p. 67.
4. Kimberlin, R. H. & Wilesmith, J. W. (1994) Ann. N. Y. Acad. Sci. 724, 210–220.
5. Imran PM, Hiremath SS, Jaleel BNF, Swamy M, Amarah U. Prion Disease and Dentistry. Int J Oral Health Med Res 2016;3(2):90-92.
6. Alper, T., Cramp, W. A., Haig, D. A. & Clarke, M. C. (1967) Nature (London) 214, 764–766.
7. Sutton JM, Dickinson J, Walker JT, Raven NDH. Methods to minimize the risks of Creutzfeldt-Jakob disease transmission by surgical procedures: where to set the standard? Clin Infect Dis. 2006 Sep 15;43(6):757–64.
8. Ryou C. Prions and prion diseases: Fundamentals and mechanistic details. J Microbiol Biotechnol 2007; 17:1059-70.
9. Race, R., Jenny, A. & Sutton, D. (1998) J. Infect. Dis. 178, 949–953.
10. Ingrosso, L., Pisani, F. & Pocchiari, M. (1999) J. Gen. Virol. 80, 3043–3047.
11. Oesch, B., Westaway, D., Wa¨lchli, M., McKinley, M. P., Kent, S. B., Aebersold, R. Barry, R. A., Tempst, P., Teplow, D. B., Hood, L. E., Prusiner, S. B. & Weissmann, C. (1985) Cell 40, 735–746.
12. Weissmann C, Enari M, Klöhn PC, Rossi D, Flechsig E. Transmission of prions. The Journal of infectious diseases. 2002 Dec 1;186(Supplement_2):S157-65.
13. Stahl, N., Baldwin, M. A., Teplow, D. B., Hood, L., Gibson, B. W., Burlingame, A. L. & Prusiner, S. B. (1993) Biochemistry 32, 1991–2002.
14. Caughey, B. W., Dong, A., Bhat, K. S., Ernst, D., Hayes, S. F. & Caughey, W. S. (1991) Biochemistry 30, 7672–7680.
15. Prusiner, S. B. (1991) Science 252, 1515–1522.
16. Guiroy DC, Shankar SK, Gibbs CJ Jr, Messenheimer JA, Das S, Gajdusek DC. Neuronal degeneration and neurofilament accumulation in the trigeminal ganglia in Creutzfeldt‑Jakob
disease. Ann Neurol 1989;25:102‑6.
17. Head MW, Ritchie D, McLoughlin V, Ironside JN. Investigation of PrPres in dental tissues in variant CJD. Br Dent J 2003;195:339‑43
18. Blanquet‑Grossard F, Sazdovitch V, Jean A, Deslys JP,Formant D, Hauw JJ, et al. Prion protein is not detectable in dental pulp from patients with Creutzfeldt‑Jakob disease.J Dent Res 2000;79:700.
19. Porter SR. Prion disease: Possible implications for oral health care. J Am Dent Assoc 2003;134:1486‑91.
20. Zeidler M, Johnstone EC, Bamber RK, Dicken CM, Fisher CJ, Francis AF, et al. New variant Creutzfeldt‑Jakob disease:Psychiatric features. Lancet 1997;350:908‑10.
21. Reuber M, Al‑Din AS, Baborie A, Chakrabraty A. New variant Creutzfeldt‑Jakob disease presenting with loss of taste and smell. J Neurol Neurosurg Psychiatry 2001;71:412‑8.
